A previous version of this article incorrectly reported that 23andMe had suspended sales of the genetic testing kits. Sales of the kits continues, but 23andMe will not offer analysis of genetic health information for customers who purchase the kits after November 22.
Google-backed startup halts results in compliance with FDA demands but will continue to provide health-related information to customers who purchased the kits before the order was issued.
People can still buy the genetic-testing startup's popular at-home testing kits, but they won't see any marketing for these products.
23andMe continues to sell its genetic sequencing tests despite a government order to stop.
Time Magazine names the Tesla Roadster, Hulu.com, Lunar Reconnaissance Orbiter, and Large Hadron Collider runners-up to the consumer DNA service.
Genetic-test start-up will reach out to participants affected by breast cancer or genetically at risk for it. Company mum on whether established research groups will take part.
Some do, and some won't have to: New service opens up 23andMe data to grant-based and ad-hoc researchers.
Genomics company 23andMe has patented a method for genetically designing a baby, from eye colour to disease risk — and fellow scientists are alarmed.
On today's show, we'll tell you about the battle between FDA and 23andMe, how to pay for anonymous medical advice with Bitcoins, the fluid grammatical changes brought on by online messaging, and a Pepsi challenge with Monster audio cables.
This could be the biggest holiday yet for online shopping, with several retailers offering week-long sales online. Also, tablets look to be a hot tech gift for 2013 and the FDA orders 23andMe to stop selling DNA testing kits.